ROCKi is given as a vasodilator to lower blood pressure (Olson, 2008), and Fasudil and other ROCKi are being tested in clinical trials for glaucoma and other vascular diseases, such as pulmonary hypertension and atherosclerosis (Olson, 2008). The gene discussed is ROCK1; the disease is glaucoma.